Stocks Health care OFIX
NASDAQ · Health careOrthofix Medical Inc. (OFIX)
Orthofix Medical Inc. brought in $835.4M of revenue over the twelve months to September 30, 2026, up 2.1% from a year earlier. It posted a net loss of $45M. In fiscal 2025 capital spending exceeded operating cash flow by $1.3M. At September 30, 2026 it held $86.3M in cash against $221.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 9, 2026.
Key facts about Orthofix Medical Inc.
- Net worth
- Orthofix Medical Inc. has a market value (market cap) of $321.8M at the latest share price, and shareholders' equity of $429.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $822.3M (+2.9% year on year), with a net loss of $92.2M. Over the 12 months to September 30, 2026: revenue $835.4M, net loss $45M.
- Cash flow
- In fiscal 2025 operations brought in $33.3M of cash; after $34.6M of capital spending, free cash flow was -$1.3M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 9, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Orthofix Medical Inc.'s next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Orthofix Medical Inc. does
Orthofix Medical Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker OFIX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $822.3M | -$92.2M | -$2.33 | -$1.3M |
| 2024 | $799.5M | -$126M | -$3.30 | -$9.1M |
| 2023 | $746.6M | -$151.4M | -$4.12 | -$106M |
| 2022 | $460.7M | -$19.7M | -$0.98 | -$32.9M |
| 2021 | $464.5M | -$38.4M | -$1.95 | $690K |
| 2020 | $406.6M | $2.5M | $0.13 | $58.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where OFIX ranks in Health care
Latest SEC filings
What Orthofix Medical Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 1.1% to $207.9M versus the same quarter last year; diluted EPS -$0.15 versus -$0.57.
- November 9, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 5, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 3.8% to $210.9M versus the same quarter last year; diluted EPS -$0.39 versus -$0.36.
- August 5, 2026
- July 2, 2026
- June 11, 2026
- May 29, 2026
- May 27, 2026Activist stake changed SCHEDULE 13D/A
Insider trades
What the people running Orthofix Medical Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $2.7M and sold $3.2M worth of shares in the last 90 days. 0% of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 2, 2026 | Fisher PatrickPresident, Global Limb Recon | Soldpre-planned (10b5-1) | 150 | $1.4K |
| October 1, 2026 | Fisher PatrickPresident, Global Limb Recon | Soldpre-planned (10b5-1) | 150 | $1.4K |
| September 21, 2026 | Juniper Investment Company, LLC10% owner | Boughtindirect | 190,000 | $1.7M |
| September 21, 2026 | Juniper Investment Company, LLC10% owner | Soldindirect | 190,000 | $1.7M |
| September 18, 2026 | Juniper Investment Company, LLC10% owner | Boughtindirect | 120,000 | $1M |
| September 18, 2026 | Juniper Investment Company, LLC10% owner | Soldindirect | 120,000 | $1M |
| September 1, 2026 | Fisher PatrickPresident, Global Limb Recon | Soldpre-planned (10b5-1) | 150 | $1.4K |
| August 18, 2026 | Fisher PatrickPresident, Global Limb Recon | Sold | 1,295 | $13.1K |
Who owns OFIX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Juniper Investment Company, LLC13D, may seek influence with 8 related filers | 11% | May 27, 2026 |
| Engine Capital Management, LP13D, may seek influence with 7 related filers | 10.9% | May 8, 2025 |
| Armistice Capital, LLC13G, passive with 1 related filers | 8.01% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 143 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Engine Capital Management, LP | 4,575,675 | +184,896 |
| Juniper Investment Company, LLC | 4,442,543 | +465,584 |
| Rubric Capital Management LP | 3,721,715 | 0 |
| BlackRock, Inc. | 3,326,560 | +118,771 |
| Paradigm Capital Management Inc | 3,300,499 | -4,400 |
| Armistice Capital, LLC | 3,264,000 | +564,000 |
| Vanguard Capital Management LLC | 1,731,108 | +75,659 |
| Geode Capital Management, LLC | 1,048,081 | +109,196 |
| State Street Corp | 953,148 | +45,716 |
| Aqr Capital Management LLC | 887,282 | +698,158 |
| Millennium Management LLC | 862,030 | -204,870 |
| AYAL Capital Advisors Ltd | 775,421 | -8,268 |
| Dimensional Fund Advisors LP | 731,638 | -109,883 |
| Jacobs Levy Equity Management, Inc | 480,836 | +101,721 |
| Goldman Sachs Group Inc | 446,140 | +121,715 |
| Vanguard Portfolio Management LLC | 404,839 | +8,271 |
| Northern Trust Corp | 363,884 | +26,546 |
| Arrowstreet Capital, Limited Partnership | 344,205 | +143,975 |
| Charles Schwab Investment Management Inc | 334,617 | +8,874 |
| Morgan Stanley | 295,656 | +98,310 |
Insiders
18 insiders reported holding 5,621,866 shares in total, about $44.4M at the last price.
| Holder | Shares |
|---|---|
| Juniper Investment Company, LLC10% owner | 3,771,2163,771,216 held indirectly |
| Engine Capital Management, LP10% owner | 382,450382,450 held indirectly |
| Calafiore MassimoPresident & CEO, Director | 320,136 |
| Vitale LucasCP&BOO | 160,449 |
| Henneman John B IIIDirector | 105,774 |
| Paolucci Michael EDirector | 102,727 |
| Andrews JulieCFO | 88,746 |
| Hannon JasonDirector | 87,662 |
| Finegan MichaelDirector | 81,617 |
| Kummeth Charles R.Director | 76,305 |
Questions about OFIX
What does Orthofix Medical Inc. do?
Orthofix Medical Inc. is a company in the Health care sector, listed on NASDAQ as OFIX. Its shares trade on NASDAQ under the ticker OFIX.
What is Orthofix Medical Inc.'s net worth?
Orthofix Medical Inc. has a market value (market cap) of $321.8M at the latest share price, and shareholders' equity of $429.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Orthofix Medical Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $45M on revenue of $835.4M.
How much revenue does Orthofix Medical Inc. make?
Over the twelve months to September 30, 2026 Orthofix Medical Inc. reported revenue of $835.4M. That is 2.1% more than a year earlier.
When did Orthofix Medical Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 9, 2026. It covers the period to September 30, 2026.
When is Orthofix Medical Inc.'s next earnings report?
Orthofix Medical Inc.'s next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare OFIX with
Follow OFIX
Get an email when Orthofix Medical Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Orthofix Medical Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.